Agile approves 1-for-50 reverse stock split
- Agile Therapeutics (NASDAQ:AGRX) said it had approved a 1-for-50 reverse stock split.
- The reverse stock split was approved by Agile’s stockholders on March 9, and will increase the per share trading price of the stock for the minimum bid price requirement for continued listing on Nasdaq.
- The reverse split will reduce the number of shares from approximately 46.60M shares to about 932,101 shares.